Welcome to our home for news – the latest headlines, all in one place. Click through to view a selection of our media coverage, industry news, videos and more.
/wp-content/uploads/botanix-logo.png00administrator/wp-content/uploads/botanix-logo.pngadministrator2019-11-25 11:17:002023-03-13 21:17:21Botanix announces landmark descheduling of synthetic CBD by DEA
/wp-content/uploads/botanix-logo.png00administrator/wp-content/uploads/botanix-logo.pngadministrator2019-11-15 11:26:192023-03-13 21:17:21Updates on 3 Health Care Stocks – Allegra, Althea and Botanix
/wp-content/uploads/botanix-logo.png00administrator/wp-content/uploads/botanix-logo.pngadministrator2019-10-24 11:29:002023-03-13 21:17:21Botanix Pharma – tell us, is it good or bad?
Botanix Pharmaceuticals has entered into a supply agreement with Purisys. Purisys has one of the industry’s longest track records and a wide range of offerings in the cannabinoid space. It currently produces all major cannabinoids relevant to pharmaceutical and consumer products. Since 2016, Purisys has also manufactured pharmaceutical-grade cannabidiol at commercial scale utilising a patented process.
Click HERE to read the article on The Market Herald.
https://botanixpharma.com/wp-content/uploads/News_3_CannabisDrug_800x800-e1594359905358.jpg800800administrator/wp-content/uploads/botanix-logo.pngadministrator2019-10-21 11:35:102023-03-13 21:17:21Botanix signs a supply agreement with Purisys
Exploring CBD’s newly found antibacterial properties
/in Latest News /by administratorBotanix announces landmark descheduling of synthetic CBD by DEA
/in Latest News /by administratorUpdates on 3 Health Care Stocks – Allegra, Althea and Botanix
/in Latest News /by administratorhttps://kalkinemedia.com/au/blog/whats-latest-with-four-health-care-stocks-heramed-allegra-althea-and-botanix
Botanix Pharma – tell us, is it good or bad?
/in Latest News /by administratorBotanix announces CBD supply agreement with Purisys
/in Latest News /by administratorBotanix signs a supply agreement with Purisys
/in Featured, Latest News /by administratorBotanix Pharmaceuticals has entered into a supply agreement with Purisys. Purisys has one of the industry’s longest track records and a wide range of offerings in the cannabinoid space. It currently produces all major cannabinoids relevant to pharmaceutical and consumer products. Since 2016, Purisys has also manufactured pharmaceutical-grade cannabidiol at commercial scale utilising a patented process.
Click HERE to read the article on The Market Herald.